Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy Study.
Journal Information
Full Title: Pain
Abbreviation: Pain
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Psychophysiology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest statement E.B., A.T.C., S.T., N.S., Bijar G., and Björn G have no conflict of interest to declare. Andrew SC Rice declares interests occurring in the past 36 months. (1) A.S.C.R. undertakes consultancy and advisory board work for Imperial College Consultants: in the past 36 months, this has included remunerated work for Confo, CombiGene, Vertex, Novartis, Orion, Shanghai SIMR Biotech & Science Practice (Wellcome Trust). (2) A.S.C.R. is named as an inventor on patents: Rice A.S.C., Vandevoorde S. and Lambert D.M Methods using N-(2-propenyl)hexadecanamide and related amides to relieve pain. WO 2005/079771; Okuse K. et al. Methods of treating pain by the inhibition of vgf activity EP13702262.0/WO2013 110945. (3) Grants and studentships: UKRI (Medical Research Council and BBSRC), Versus Arthritis, Alan and Sheila Diamond Trust, Royal British Legion, European Commission, Ministry of Defence, Dr Jennie Gwynn Bequests, The British Pain Society, and Royal Society of Medicine. David Bennett has acted as a consultant in the past 2 years for Aditum Bio, Amgen, Biointervene, Bristows, LatigoBio, GSK, Ionis, Lexicon Pharmaceuticals, Lilly, Neuvati, Olipass, Regeneron, Replay, and TheraNexus on behalf of the Oxford University Innovation."
"Funding: Emmanuel Bäckryd reports grants from NEURO Sweden, and ALF Grants, Region Östergötland. D.L.B., A.C.T., and A.S.C.R., are members of the DOLORisk consortium funded by the European Commission Horizon 2020 (ID633491), which received funding from European Union's Seventh Framework Program (FP7/2007-2013). D.L.B., and A.C.T. are members of the International Diabetic Neuropathy Consortium (IDNC) research program, which is supported by a Novo Nordisk Foundation Challenge Program grant (Grant number NNF14OC0011633). A.C.T. is supported by Academy of Medical Sciences Starter Grant SGL022\1086 and is an Honorary Senior Research Fellow and Carnegie-Wits Diaspora Fellow at the Brain Function Research Group, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. This research was funded in whole, or in part, by the Wellcome Trust [Grant number Ref. No. 083259]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025